BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24929097)

  • 1. Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.
    Munthali C; Taegtmeyer M; Garner PG; Lalloo DG; Squire SB; Corbett EL; Ford N; MacPherson P
    J Int AIDS Soc; 2014; 17(1):18932. PubMed ID: 24929097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
    Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
    Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
    Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.
    Rosen S; Fox MP
    PLoS Med; 2011 Jul; 8(7):e1001056. PubMed ID: 21811403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness.
    Fox MP; Rosen S; Geldsetzer P; Bärnighausen T; Negussie E; Beanland R
    J Int AIDS Soc; 2016; 19(1):20888. PubMed ID: 27507249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings.
    Carter RJ; Dugan K; El-Sadr WM; Myer L; Otieno J; Pungpapong N; Toro PL; Abrams EJ;
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):404-10. PubMed ID: 20595905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.
    Mugglin C; Wandeler G; Estill J; Egger M; Bender N; Davies MA; Keiser O
    PLoS One; 2013; 8(2):e56446. PubMed ID: 23437135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.
    Johnson OO; Benjamin DK; Benjamin DK; Schimana W; Tillekeratne LG; Crump JA; Landman KZ; Kinabo GD; Mmbaga B; Msuya LJ; Shao JF; Swai ME; Cunningham CK
    Pediatr Infect Dis J; 2009 Jun; 28(6):493-7. PubMed ID: 19436238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.
    Kranzer K; Govindasamy D; Ford N; Johnston V; Lawn SD
    J Int AIDS Soc; 2012 Nov; 15(2):17383. PubMed ID: 23199799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study.
    Bor J; Ahmed S; Fox MP; Rosen S; Meyer-Rath G; Katz IT; Tanser F; Pillay D; Bärnighausen T
    PLoS One; 2017; 12(6):e0178249. PubMed ID: 28617805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
    Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
    PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
    PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.
    Diomandé FV; Bissagnéné E; Nkengasong JN; Maurice C; Monga B; Laga M; Nolan ML
    AIDS; 2003 Jul; 17 Suppl 3():S87-93. PubMed ID: 14565614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of undernutrition and associated factors among adults taking antiretroviral therapy in sub-Saharan Africa: A systematic review and meta-analysis.
    Seid A; Seid O; Workineh Y; Dessie G; Bitew ZW
    PLoS One; 2023; 18(3):e0283502. PubMed ID: 36961844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.